nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—ABCC2—esophageal cancer	0.269	0.731	CbGaD
Lamivudine—ABCB1—esophageal cancer	0.0991	0.269	CbGaD
Lamivudine—ABCC3—Cisplatin—esophageal cancer	0.0666	0.167	CbGbCtD
Lamivudine—ABCC3—Methotrexate—esophageal cancer	0.0433	0.108	CbGbCtD
Lamivudine—SLC22A2—Cisplatin—esophageal cancer	0.0371	0.0928	CbGbCtD
Lamivudine—ABCC2—Carboplatin—esophageal cancer	0.0354	0.0886	CbGbCtD
Lamivudine—ABCC4—Methotrexate—esophageal cancer	0.033	0.0827	CbGbCtD
Lamivudine—ABCG2—Carboplatin—esophageal cancer	0.032	0.0801	CbGbCtD
Lamivudine—ABCC2—Cisplatin—esophageal cancer	0.0303	0.0757	CbGbCtD
Lamivudine—ABCG2—Cisplatin—esophageal cancer	0.0274	0.0685	CbGbCtD
Lamivudine—ABCC1—Methotrexate—esophageal cancer	0.0266	0.0664	CbGbCtD
Lamivudine—ABCC2—Methotrexate—esophageal cancer	0.0197	0.0492	CbGbCtD
Lamivudine—ABCG2—Methotrexate—esophageal cancer	0.0178	0.0445	CbGbCtD
Lamivudine—SLC22A6—Methotrexate—esophageal cancer	0.0144	0.036	CbGbCtD
Lamivudine—ABCB1—Cisplatin—esophageal cancer	0.00987	0.0247	CbGbCtD
Lamivudine—ABCB1—Methotrexate—esophageal cancer	0.00641	0.016	CbGbCtD
Lamivudine—PCYT2—digestive system—esophageal cancer	0.00298	0.0661	CbGeAlD
Lamivudine—NME1—neck—esophageal cancer	0.00262	0.0582	CbGeAlD
Lamivudine—PGK1—digestive system—esophageal cancer	0.00256	0.0568	CbGeAlD
Lamivudine—PCYT1A—digestive system—esophageal cancer	0.00203	0.045	CbGeAlD
Lamivudine—NT5C—lung—esophageal cancer	0.0018	0.0401	CbGeAlD
Lamivudine—PCYT1A—lung—esophageal cancer	0.00169	0.0376	CbGeAlD
Lamivudine—CMPK1—bronchus—esophageal cancer	0.00169	0.0376	CbGeAlD
Lamivudine—NME2—epithelium—esophageal cancer	0.00168	0.0373	CbGeAlD
Lamivudine—CMPK1—smooth muscle tissue—esophageal cancer	0.00165	0.0367	CbGeAlD
Lamivudine—NME2—bronchus—esophageal cancer	0.00165	0.0367	CbGeAlD
Lamivudine—NME1—digestive system—esophageal cancer	0.00136	0.0301	CbGeAlD
Lamivudine—NME1-NME2—lymph node—esophageal cancer	0.00133	0.0296	CbGeAlD
Lamivudine—CMPK1—digestive system—esophageal cancer	0.00131	0.029	CbGeAlD
Lamivudine—NME2—digestive system—esophageal cancer	0.00128	0.0284	CbGeAlD
Lamivudine—NT5C—lymph node—esophageal cancer	0.00123	0.0274	CbGeAlD
Lamivudine—NME1—lung—esophageal cancer	0.00113	0.0251	CbGeAlD
Lamivudine—CMPK1—lung—esophageal cancer	0.00109	0.0242	CbGeAlD
Lamivudine—NME2—lung—esophageal cancer	0.00107	0.0237	CbGeAlD
Lamivudine—DCK—bronchus—esophageal cancer	0.000842	0.0187	CbGeAlD
Lamivudine—SLC22A2—digestive system—esophageal cancer	0.000785	0.0174	CbGeAlD
Lamivudine—NME1—lymph node—esophageal cancer	0.000774	0.0172	CbGeAlD
Lamivudine—DCK—trachea—esophageal cancer	0.000756	0.0168	CbGeAlD
Lamivudine—CMPK1—lymph node—esophageal cancer	0.000746	0.0166	CbGeAlD
Lamivudine—NME2—lymph node—esophageal cancer	0.000729	0.0162	CbGeAlD
Lamivudine—SLC22A3—smooth muscle tissue—esophageal cancer	0.000672	0.0149	CbGeAlD
Lamivudine—ABCC4—bronchus—esophageal cancer	0.000665	0.0148	CbGeAlD
Lamivudine—DCK—digestive system—esophageal cancer	0.000651	0.0144	CbGeAlD
Lamivudine—ABCC3—digestive system—esophageal cancer	0.000623	0.0138	CbGeAlD
Lamivudine—ABCC1—bronchus—esophageal cancer	0.000567	0.0126	CbGeAlD
Lamivudine—DCK—lung—esophageal cancer	0.000543	0.0121	CbGeAlD
Lamivudine—ABCC3—lung—esophageal cancer	0.00052	0.0116	CbGeAlD
Lamivudine—ABCC4—digestive system—esophageal cancer	0.000514	0.0114	CbGeAlD
Lamivudine—ABCC1—trachea—esophageal cancer	0.00051	0.0113	CbGeAlD
Lamivudine—ABCC2—digestive system—esophageal cancer	0.000498	0.0111	CbGeAlD
Lamivudine—SLC22A3—lung—esophageal cancer	0.000443	0.00983	CbGeAlD
Lamivudine—ABCC4—lung—esophageal cancer	0.000429	0.00953	CbGeAlD
Lamivudine—Phlebitis—Cisplatin—esophageal cancer	0.000409	0.00637	CcSEcCtD
Lamivudine—Polyuria—Cisplatin—esophageal cancer	0.000402	0.00625	CcSEcCtD
Lamivudine—Rectal haemorrhage—Capecitabine—esophageal cancer	0.000396	0.00617	CcSEcCtD
Lamivudine—Bone marrow depression—Methotrexate—esophageal cancer	0.000395	0.00614	CcSEcCtD
Lamivudine—Deafness—Cisplatin—esophageal cancer	0.000394	0.00613	CcSEcCtD
Lamivudine—Oropharyngeal pain—Capecitabine—esophageal cancer	0.000394	0.00613	CcSEcCtD
Lamivudine—Hearing impaired—Capecitabine—esophageal cancer	0.000376	0.00585	CcSEcCtD
Lamivudine—DCK—lymph node—esophageal cancer	0.000372	0.00825	CbGeAlD
Lamivudine—Inflammation—Capecitabine—esophageal cancer	0.000369	0.00574	CcSEcCtD
Lamivudine—ABCC1—lung—esophageal cancer	0.000366	0.00813	CbGeAlD
Lamivudine—ABCC3—lymph node—esophageal cancer	0.000356	0.0079	CbGeAlD
Lamivudine—Neuropathy—Capecitabine—esophageal cancer	0.000336	0.00523	CcSEcCtD
Lamivudine—Dehydration—Cisplatin—esophageal cancer	0.000328	0.0051	CcSEcCtD
Lamivudine—Mouth ulceration—Capecitabine—esophageal cancer	0.000324	0.00504	CcSEcCtD
Lamivudine—Urine output increased—Capecitabine—esophageal cancer	0.000324	0.00504	CcSEcCtD
Lamivudine—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.000318	0.00494	CcSEcCtD
Lamivudine—Cramp muscle—Cisplatin—esophageal cancer	0.000318	0.00494	CcSEcCtD
Lamivudine—Nasopharyngitis—Cisplatin—esophageal cancer	0.000315	0.00491	CcSEcCtD
Lamivudine—Sepsis—Capecitabine—esophageal cancer	0.000311	0.00484	CcSEcCtD
Lamivudine—ABCG2—lung—esophageal cancer	0.000303	0.00673	CbGeAlD
Lamivudine—SLC22A3—lymph node—esophageal cancer	0.000303	0.00673	CbGeAlD
Lamivudine—Phlebitis—Capecitabine—esophageal cancer	0.000302	0.0047	CcSEcCtD
Lamivudine—Sleep disorder—Capecitabine—esophageal cancer	0.0003	0.00467	CcSEcCtD
Lamivudine—Pancreatitis—Cisplatin—esophageal cancer	0.000299	0.00465	CcSEcCtD
Lamivudine—Sweating increased—Cisplatin—esophageal cancer	0.000297	0.00462	CcSEcCtD
Lamivudine—Polyuria—Capecitabine—esophageal cancer	0.000296	0.00461	CcSEcCtD
Lamivudine—Bone disorder—Methotrexate—esophageal cancer	0.000295	0.00459	CcSEcCtD
Lamivudine—ABCC4—lymph node—esophageal cancer	0.000294	0.00652	CbGeAlD
Lamivudine—Gastroenteritis—Capecitabine—esophageal cancer	0.000293	0.00456	CcSEcCtD
Lamivudine—Abdominal discomfort—Cisplatin—esophageal cancer	0.000292	0.00455	CcSEcCtD
Lamivudine—Deafness—Capecitabine—esophageal cancer	0.000291	0.00452	CcSEcCtD
Lamivudine—Pancytopenia—Cisplatin—esophageal cancer	0.000289	0.0045	CcSEcCtD
Lamivudine—ABCC2—lymph node—esophageal cancer	0.000284	0.00631	CbGeAlD
Lamivudine—Inflammation—Methotrexate—esophageal cancer	0.000275	0.00428	CcSEcCtD
Lamivudine—Thirst—Capecitabine—esophageal cancer	0.000273	0.00425	CcSEcCtD
Lamivudine—Renal impairment—Capecitabine—esophageal cancer	0.000273	0.00425	CcSEcCtD
Lamivudine—Vasculitis—Methotrexate—esophageal cancer	0.000273	0.00425	CcSEcCtD
Lamivudine—Renal failure—Cisplatin—esophageal cancer	0.000267	0.00416	CcSEcCtD
Lamivudine—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000266	0.00415	CcSEcCtD
Lamivudine—Stomatitis—Cisplatin—esophageal cancer	0.000265	0.00412	CcSEcCtD
Lamivudine—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000257	0.004	CcSEcCtD
Lamivudine—Migraine—Capecitabine—esophageal cancer	0.000256	0.00398	CcSEcCtD
Lamivudine—ABCC1—lymph node—esophageal cancer	0.00025	0.00556	CbGeAlD
Lamivudine—Aplastic anaemia—Methotrexate—esophageal cancer	0.00025	0.00389	CcSEcCtD
Lamivudine—Mood swings—Capecitabine—esophageal cancer	0.000246	0.00383	CcSEcCtD
Lamivudine—Dehydration—Capecitabine—esophageal cancer	0.000242	0.00376	CcSEcCtD
Lamivudine—Mouth ulceration—Methotrexate—esophageal cancer	0.000241	0.00375	CcSEcCtD
Lamivudine—Urine output increased—Methotrexate—esophageal cancer	0.000241	0.00375	CcSEcCtD
Lamivudine—Liver function test abnormal—Capecitabine—esophageal cancer	0.00024	0.00373	CcSEcCtD
Lamivudine—Connective tissue disorder—Cisplatin—esophageal cancer	0.00024	0.00373	CcSEcCtD
Lamivudine—Gynaecomastia—Methotrexate—esophageal cancer	0.000239	0.00371	CcSEcCtD
Lamivudine—Abdominal pain upper—Capecitabine—esophageal cancer	0.000237	0.00369	CcSEcCtD
Lamivudine—ABCB1—epithelium—esophageal cancer	0.000235	0.00522	CbGeAlD
Lamivudine—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000234	0.00364	CcSEcCtD
Lamivudine—Nasopharyngitis—Capecitabine—esophageal cancer	0.000232	0.00362	CcSEcCtD
Lamivudine—Sepsis—Methotrexate—esophageal cancer	0.000231	0.0036	CcSEcCtD
Lamivudine—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000229	0.00357	CcSEcCtD
Lamivudine—Muscular weakness—Capecitabine—esophageal cancer	0.000229	0.00357	CcSEcCtD
Lamivudine—Lymphadenopathy—Methotrexate—esophageal cancer	0.000227	0.00353	CcSEcCtD
Lamivudine—Abdominal distension—Capecitabine—esophageal cancer	0.000226	0.00352	CcSEcCtD
Lamivudine—Dysphagia—Capecitabine—esophageal cancer	0.000225	0.0035	CcSEcCtD
Lamivudine—Influenza—Capecitabine—esophageal cancer	0.000225	0.0035	CcSEcCtD
Lamivudine—Polyuria—Methotrexate—esophageal cancer	0.00022	0.00343	CcSEcCtD
Lamivudine—Immune system disorder—Cisplatin—esophageal cancer	0.00022	0.00343	CcSEcCtD
Lamivudine—Mediastinal disorder—Cisplatin—esophageal cancer	0.00022	0.00342	CcSEcCtD
Lamivudine—Sweating increased—Capecitabine—esophageal cancer	0.000219	0.00341	CcSEcCtD
Lamivudine—Bronchitis—Capecitabine—esophageal cancer	0.000216	0.00336	CcSEcCtD
Lamivudine—Alopecia—Cisplatin—esophageal cancer	0.000216	0.00335	CcSEcCtD
Lamivudine—Abdominal discomfort—Capecitabine—esophageal cancer	0.000215	0.00335	CcSEcCtD
Lamivudine—Pancytopenia—Capecitabine—esophageal cancer	0.000213	0.00332	CcSEcCtD
Lamivudine—Malnutrition—Cisplatin—esophageal cancer	0.000212	0.0033	CcSEcCtD
Lamivudine—Erythema—Cisplatin—esophageal cancer	0.000212	0.0033	CcSEcCtD
Lamivudine—Dysuria—Capecitabine—esophageal cancer	0.00021	0.00327	CcSEcCtD
Lamivudine—Neutropenia—Capecitabine—esophageal cancer	0.00021	0.00327	CcSEcCtD
Lamivudine—Flatulence—Cisplatin—esophageal cancer	0.000209	0.00326	CcSEcCtD
Lamivudine—ABCB1—trachea—esophageal cancer	0.000208	0.00462	CbGeAlD
Lamivudine—ABCG2—lymph node—esophageal cancer	0.000207	0.0046	CbGeAlD
Lamivudine—Muscle spasms—Cisplatin—esophageal cancer	0.000204	0.00318	CcSEcCtD
Lamivudine—Hyperglycaemia—Capecitabine—esophageal cancer	0.000203	0.00315	CcSEcCtD
Lamivudine—Depression—Capecitabine—esophageal cancer	0.0002	0.00311	CcSEcCtD
Lamivudine—Tremor—Cisplatin—esophageal cancer	0.000199	0.0031	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000199	0.00309	CcSEcCtD
Lamivudine—Ill-defined disorder—Cisplatin—esophageal cancer	0.000197	0.00307	CcSEcCtD
Lamivudine—Renal failure—Capecitabine—esophageal cancer	0.000197	0.00306	CcSEcCtD
Lamivudine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000196	0.00306	CcSEcCtD
Lamivudine—Anaemia—Cisplatin—esophageal cancer	0.000196	0.00305	CcSEcCtD
Lamivudine—Jaundice—Capecitabine—esophageal cancer	0.000195	0.00304	CcSEcCtD
Lamivudine—Stomatitis—Capecitabine—esophageal cancer	0.000195	0.00304	CcSEcCtD
Lamivudine—Malaise—Cisplatin—esophageal cancer	0.000192	0.00298	CcSEcCtD
Lamivudine—Leukopenia—Cisplatin—esophageal cancer	0.00019	0.00296	CcSEcCtD
Lamivudine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000189	0.00295	CcSEcCtD
Lamivudine—Epistaxis—Capecitabine—esophageal cancer	0.000189	0.00294	CcSEcCtD
Lamivudine—Agranulocytosis—Capecitabine—esophageal cancer	0.000187	0.00291	CcSEcCtD
Lamivudine—Convulsion—Cisplatin—esophageal cancer	0.000184	0.00286	CcSEcCtD
Lamivudine—Mood swings—Methotrexate—esophageal cancer	0.000183	0.00285	CcSEcCtD
Lamivudine—Myalgia—Cisplatin—esophageal cancer	0.000181	0.00281	CcSEcCtD
Lamivudine—Rhinitis—Capecitabine—esophageal cancer	0.00018	0.00281	CcSEcCtD
Lamivudine—Anxiety—Cisplatin—esophageal cancer	0.00018	0.0028	CcSEcCtD
Lamivudine—Hepatitis—Capecitabine—esophageal cancer	0.00018	0.0028	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00018	0.00279	CcSEcCtD
Lamivudine—ABCB1—digestive system—esophageal cancer	0.000179	0.00397	CbGeAlD
Lamivudine—Hypoaesthesia—Capecitabine—esophageal cancer	0.000179	0.00278	CcSEcCtD
Lamivudine—Liver function test abnormal—Methotrexate—esophageal cancer	0.000179	0.00278	CcSEcCtD
Lamivudine—Discomfort—Cisplatin—esophageal cancer	0.000179	0.00278	CcSEcCtD
Lamivudine—Pharyngitis—Capecitabine—esophageal cancer	0.000178	0.00278	CcSEcCtD
Lamivudine—Connective tissue disorder—Capecitabine—esophageal cancer	0.000177	0.00275	CcSEcCtD
Lamivudine—Oedema—Cisplatin—esophageal cancer	0.000173	0.0027	CcSEcCtD
Lamivudine—Anaphylactic shock—Cisplatin—esophageal cancer	0.000173	0.0027	CcSEcCtD
Lamivudine—Infection—Cisplatin—esophageal cancer	0.000172	0.00268	CcSEcCtD
Lamivudine—Erythema multiforme—Capecitabine—esophageal cancer	0.00017	0.00265	CcSEcCtD
Lamivudine—Nervous system disorder—Cisplatin—esophageal cancer	0.00017	0.00264	CcSEcCtD
Lamivudine—Thrombocytopenia—Cisplatin—esophageal cancer	0.00017	0.00264	CcSEcCtD
Lamivudine—Skin disorder—Cisplatin—esophageal cancer	0.000168	0.00262	CcSEcCtD
Lamivudine—Hyperhidrosis—Cisplatin—esophageal cancer	0.000168	0.00261	CcSEcCtD
Lamivudine—Anorexia—Cisplatin—esophageal cancer	0.000165	0.00257	CcSEcCtD
Lamivudine—Pancreatitis—Methotrexate—esophageal cancer	0.000164	0.00255	CcSEcCtD
Lamivudine—Immune system disorder—Capecitabine—esophageal cancer	0.000162	0.00253	CcSEcCtD
Lamivudine—Mediastinal disorder—Capecitabine—esophageal cancer	0.000162	0.00252	CcSEcCtD
Lamivudine—Hypotension—Cisplatin—esophageal cancer	0.000162	0.00252	CcSEcCtD
Lamivudine—Chills—Capecitabine—esophageal cancer	0.000161	0.00251	CcSEcCtD
Lamivudine—Abdominal discomfort—Methotrexate—esophageal cancer	0.00016	0.00249	CcSEcCtD
Lamivudine—Alopecia—Capecitabine—esophageal cancer	0.000159	0.00247	CcSEcCtD
Lamivudine—Pancytopenia—Methotrexate—esophageal cancer	0.000159	0.00247	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000158	0.00246	CcSEcCtD
Lamivudine—Malnutrition—Capecitabine—esophageal cancer	0.000157	0.00244	CcSEcCtD
Lamivudine—Erythema—Capecitabine—esophageal cancer	0.000157	0.00244	CcSEcCtD
Lamivudine—Neutropenia—Methotrexate—esophageal cancer	0.000156	0.00243	CcSEcCtD
Lamivudine—Dysuria—Methotrexate—esophageal cancer	0.000156	0.00243	CcSEcCtD
Lamivudine—Paraesthesia—Cisplatin—esophageal cancer	0.000156	0.00242	CcSEcCtD
Lamivudine—Dyspnoea—Cisplatin—esophageal cancer	0.000155	0.0024	CcSEcCtD
Lamivudine—Flatulence—Capecitabine—esophageal cancer	0.000154	0.0024	CcSEcCtD
Lamivudine—Dysgeusia—Capecitabine—esophageal cancer	0.000153	0.00239	CcSEcCtD
Lamivudine—Back pain—Capecitabine—esophageal cancer	0.000151	0.00236	CcSEcCtD
Lamivudine—Decreased appetite—Cisplatin—esophageal cancer	0.000151	0.00234	CcSEcCtD
Lamivudine—Muscle spasms—Capecitabine—esophageal cancer	0.00015	0.00234	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00015	0.00233	CcSEcCtD
Lamivudine—ABCB1—lung—esophageal cancer	0.000149	0.00332	CbGeAlD
Lamivudine—Depression—Methotrexate—esophageal cancer	0.000149	0.00231	CcSEcCtD
Lamivudine—Pain—Cisplatin—esophageal cancer	0.000148	0.00231	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000148	0.0023	CcSEcCtD
Lamivudine—Tremor—Capecitabine—esophageal cancer	0.000147	0.00228	CcSEcCtD
Lamivudine—Renal failure—Methotrexate—esophageal cancer	0.000147	0.00228	CcSEcCtD
Lamivudine—Stomatitis—Methotrexate—esophageal cancer	0.000145	0.00226	CcSEcCtD
Lamivudine—Ill-defined disorder—Capecitabine—esophageal cancer	0.000145	0.00226	CcSEcCtD
Lamivudine—Anaemia—Capecitabine—esophageal cancer	0.000145	0.00225	CcSEcCtD
Lamivudine—Sweating—Methotrexate—esophageal cancer	0.000143	0.00222	CcSEcCtD
Lamivudine—Feeling abnormal—Cisplatin—esophageal cancer	0.000143	0.00222	CcSEcCtD
Lamivudine—Malaise—Capecitabine—esophageal cancer	0.000141	0.0022	CcSEcCtD
Lamivudine—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000141	0.00219	CcSEcCtD
Lamivudine—Epistaxis—Methotrexate—esophageal cancer	0.000141	0.00219	CcSEcCtD
Lamivudine—Vertigo—Capecitabine—esophageal cancer	0.000141	0.00219	CcSEcCtD
Lamivudine—Syncope—Capecitabine—esophageal cancer	0.00014	0.00218	CcSEcCtD
Lamivudine—Leukopenia—Capecitabine—esophageal cancer	0.00014	0.00218	CcSEcCtD
Lamivudine—Agranulocytosis—Methotrexate—esophageal cancer	0.000139	0.00217	CcSEcCtD
Lamivudine—Loss of consciousness—Capecitabine—esophageal cancer	0.000138	0.00214	CcSEcCtD
Lamivudine—Body temperature increased—Cisplatin—esophageal cancer	0.000137	0.00213	CcSEcCtD
Lamivudine—Cough—Capecitabine—esophageal cancer	0.000137	0.00213	CcSEcCtD
Lamivudine—Hepatitis—Methotrexate—esophageal cancer	0.000134	0.00208	CcSEcCtD
Lamivudine—Arthralgia—Capecitabine—esophageal cancer	0.000133	0.00207	CcSEcCtD
Lamivudine—Myalgia—Capecitabine—esophageal cancer	0.000133	0.00207	CcSEcCtD
Lamivudine—Chest pain—Capecitabine—esophageal cancer	0.000133	0.00207	CcSEcCtD
Lamivudine—Pharyngitis—Methotrexate—esophageal cancer	0.000133	0.00207	CcSEcCtD
Lamivudine—Anxiety—Capecitabine—esophageal cancer	0.000133	0.00207	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000132	0.00206	CcSEcCtD
Lamivudine—Discomfort—Capecitabine—esophageal cancer	0.000132	0.00205	CcSEcCtD
Lamivudine—Dry mouth—Capecitabine—esophageal cancer	0.00013	0.00203	CcSEcCtD
Lamivudine—Confusional state—Capecitabine—esophageal cancer	0.000129	0.002	CcSEcCtD
Lamivudine—Oedema—Capecitabine—esophageal cancer	0.000128	0.00199	CcSEcCtD
Lamivudine—Hypersensitivity—Cisplatin—esophageal cancer	0.000128	0.00199	CcSEcCtD
Lamivudine—Infection—Capecitabine—esophageal cancer	0.000127	0.00198	CcSEcCtD
Lamivudine—Erythema multiforme—Methotrexate—esophageal cancer	0.000127	0.00197	CcSEcCtD
Lamivudine—Shock—Capecitabine—esophageal cancer	0.000126	0.00196	CcSEcCtD
Lamivudine—Nervous system disorder—Capecitabine—esophageal cancer	0.000125	0.00195	CcSEcCtD
Lamivudine—Thrombocytopenia—Capecitabine—esophageal cancer	0.000125	0.00195	CcSEcCtD
Lamivudine—Asthenia—Cisplatin—esophageal cancer	0.000124	0.00194	CcSEcCtD
Lamivudine—Skin disorder—Capecitabine—esophageal cancer	0.000124	0.00193	CcSEcCtD
Lamivudine—Hyperhidrosis—Capecitabine—esophageal cancer	0.000124	0.00192	CcSEcCtD
Lamivudine—Anorexia—Capecitabine—esophageal cancer	0.000122	0.0019	CcSEcCtD
Lamivudine—Immune system disorder—Methotrexate—esophageal cancer	0.000121	0.00188	CcSEcCtD
Lamivudine—Mediastinal disorder—Methotrexate—esophageal cancer	0.000121	0.00188	CcSEcCtD
Lamivudine—Chills—Methotrexate—esophageal cancer	0.00012	0.00187	CcSEcCtD
Lamivudine—Hypotension—Capecitabine—esophageal cancer	0.000119	0.00186	CcSEcCtD
Lamivudine—Diarrhoea—Cisplatin—esophageal cancer	0.000119	0.00185	CcSEcCtD
Lamivudine—Alopecia—Methotrexate—esophageal cancer	0.000118	0.00184	CcSEcCtD
Lamivudine—Malnutrition—Methotrexate—esophageal cancer	0.000117	0.00181	CcSEcCtD
Lamivudine—Erythema—Methotrexate—esophageal cancer	0.000117	0.00181	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000116	0.00181	CcSEcCtD
Lamivudine—Insomnia—Capecitabine—esophageal cancer	0.000116	0.0018	CcSEcCtD
Lamivudine—Paraesthesia—Capecitabine—esophageal cancer	0.000115	0.00179	CcSEcCtD
Lamivudine—Dysgeusia—Methotrexate—esophageal cancer	0.000114	0.00178	CcSEcCtD
Lamivudine—Dyspnoea—Capecitabine—esophageal cancer	0.000114	0.00177	CcSEcCtD
Lamivudine—Back pain—Methotrexate—esophageal cancer	0.000113	0.00175	CcSEcCtD
Lamivudine—Dyspepsia—Capecitabine—esophageal cancer	0.000112	0.00175	CcSEcCtD
Lamivudine—Decreased appetite—Capecitabine—esophageal cancer	0.000111	0.00173	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00011	0.00172	CcSEcCtD
Lamivudine—Vomiting—Cisplatin—esophageal cancer	0.00011	0.00171	CcSEcCtD
Lamivudine—Fatigue—Capecitabine—esophageal cancer	0.00011	0.00171	CcSEcCtD
Lamivudine—Rash—Cisplatin—esophageal cancer	0.000109	0.0017	CcSEcCtD
Lamivudine—Pain—Capecitabine—esophageal cancer	0.000109	0.0017	CcSEcCtD
Lamivudine—Constipation—Capecitabine—esophageal cancer	0.000109	0.0017	CcSEcCtD
Lamivudine—Dermatitis—Cisplatin—esophageal cancer	0.000109	0.0017	CcSEcCtD
Lamivudine—Ill-defined disorder—Methotrexate—esophageal cancer	0.000108	0.00168	CcSEcCtD
Lamivudine—Anaemia—Methotrexate—esophageal cancer	0.000108	0.00168	CcSEcCtD
Lamivudine—Feeling abnormal—Capecitabine—esophageal cancer	0.000105	0.00164	CcSEcCtD
Lamivudine—Malaise—Methotrexate—esophageal cancer	0.000105	0.00164	CcSEcCtD
Lamivudine—Vertigo—Methotrexate—esophageal cancer	0.000105	0.00163	CcSEcCtD
Lamivudine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000104	0.00163	CcSEcCtD
Lamivudine—Leukopenia—Methotrexate—esophageal cancer	0.000104	0.00162	CcSEcCtD
Lamivudine—Nausea—Cisplatin—esophageal cancer	0.000103	0.0016	CcSEcCtD
Lamivudine—ABCB1—lymph node—esophageal cancer	0.000102	0.00227	CbGeAlD
Lamivudine—Cough—Methotrexate—esophageal cancer	0.000102	0.00158	CcSEcCtD
Lamivudine—Urticaria—Capecitabine—esophageal cancer	0.000101	0.00158	CcSEcCtD
Lamivudine—Abdominal pain—Capecitabine—esophageal cancer	0.000101	0.00157	CcSEcCtD
Lamivudine—Body temperature increased—Capecitabine—esophageal cancer	0.000101	0.00157	CcSEcCtD
Lamivudine—Convulsion—Methotrexate—esophageal cancer	0.000101	0.00157	CcSEcCtD
Lamivudine—Arthralgia—Methotrexate—esophageal cancer	9.92e-05	0.00154	CcSEcCtD
Lamivudine—Chest pain—Methotrexate—esophageal cancer	9.92e-05	0.00154	CcSEcCtD
Lamivudine—Myalgia—Methotrexate—esophageal cancer	9.92e-05	0.00154	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	9.85e-05	0.00153	CcSEcCtD
Lamivudine—Discomfort—Methotrexate—esophageal cancer	9.8e-05	0.00153	CcSEcCtD
Lamivudine—Confusional state—Methotrexate—esophageal cancer	9.59e-05	0.00149	CcSEcCtD
Lamivudine—Anaphylactic shock—Methotrexate—esophageal cancer	9.51e-05	0.00148	CcSEcCtD
Lamivudine—Infection—Methotrexate—esophageal cancer	9.45e-05	0.00147	CcSEcCtD
Lamivudine—Hypersensitivity—Capecitabine—esophageal cancer	9.41e-05	0.00146	CcSEcCtD
Lamivudine—Nervous system disorder—Methotrexate—esophageal cancer	9.33e-05	0.00145	CcSEcCtD
Lamivudine—Thrombocytopenia—Methotrexate—esophageal cancer	9.31e-05	0.00145	CcSEcCtD
Lamivudine—Skin disorder—Methotrexate—esophageal cancer	9.24e-05	0.00144	CcSEcCtD
Lamivudine—Hyperhidrosis—Methotrexate—esophageal cancer	9.19e-05	0.00143	CcSEcCtD
Lamivudine—Asthenia—Capecitabine—esophageal cancer	9.17e-05	0.00143	CcSEcCtD
Lamivudine—Anorexia—Methotrexate—esophageal cancer	9.07e-05	0.00141	CcSEcCtD
Lamivudine—Pruritus—Capecitabine—esophageal cancer	9.04e-05	0.00141	CcSEcCtD
Lamivudine—Hypotension—Methotrexate—esophageal cancer	8.89e-05	0.00138	CcSEcCtD
Lamivudine—Diarrhoea—Capecitabine—esophageal cancer	8.74e-05	0.00136	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	8.66e-05	0.00135	CcSEcCtD
Lamivudine—Insomnia—Methotrexate—esophageal cancer	8.6e-05	0.00134	CcSEcCtD
Lamivudine—Paraesthesia—Methotrexate—esophageal cancer	8.54e-05	0.00133	CcSEcCtD
Lamivudine—Dyspnoea—Methotrexate—esophageal cancer	8.48e-05	0.00132	CcSEcCtD
Lamivudine—Somnolence—Methotrexate—esophageal cancer	8.45e-05	0.00132	CcSEcCtD
Lamivudine—Dizziness—Capecitabine—esophageal cancer	8.45e-05	0.00131	CcSEcCtD
Lamivudine—Dyspepsia—Methotrexate—esophageal cancer	8.37e-05	0.0013	CcSEcCtD
Lamivudine—Decreased appetite—Methotrexate—esophageal cancer	8.27e-05	0.00129	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Methotrexate—esophageal cancer	8.21e-05	0.00128	CcSEcCtD
Lamivudine—Fatigue—Methotrexate—esophageal cancer	8.2e-05	0.00128	CcSEcCtD
Lamivudine—Pain—Methotrexate—esophageal cancer	8.13e-05	0.00127	CcSEcCtD
Lamivudine—Vomiting—Capecitabine—esophageal cancer	8.12e-05	0.00126	CcSEcCtD
Lamivudine—Rash—Capecitabine—esophageal cancer	8.06e-05	0.00125	CcSEcCtD
Lamivudine—Dermatitis—Capecitabine—esophageal cancer	8.05e-05	0.00125	CcSEcCtD
Lamivudine—Headache—Capecitabine—esophageal cancer	8e-05	0.00125	CcSEcCtD
Lamivudine—Feeling abnormal—Methotrexate—esophageal cancer	7.84e-05	0.00122	CcSEcCtD
Lamivudine—Gastrointestinal pain—Methotrexate—esophageal cancer	7.78e-05	0.00121	CcSEcCtD
Lamivudine—Nausea—Capecitabine—esophageal cancer	7.59e-05	0.00118	CcSEcCtD
Lamivudine—Urticaria—Methotrexate—esophageal cancer	7.56e-05	0.00118	CcSEcCtD
Lamivudine—Abdominal pain—Methotrexate—esophageal cancer	7.52e-05	0.00117	CcSEcCtD
Lamivudine—Body temperature increased—Methotrexate—esophageal cancer	7.52e-05	0.00117	CcSEcCtD
Lamivudine—Hypersensitivity—Methotrexate—esophageal cancer	7.01e-05	0.00109	CcSEcCtD
Lamivudine—Asthenia—Methotrexate—esophageal cancer	6.82e-05	0.00106	CcSEcCtD
Lamivudine—Pruritus—Methotrexate—esophageal cancer	6.73e-05	0.00105	CcSEcCtD
Lamivudine—Diarrhoea—Methotrexate—esophageal cancer	6.51e-05	0.00101	CcSEcCtD
Lamivudine—Dizziness—Methotrexate—esophageal cancer	6.29e-05	0.000979	CcSEcCtD
Lamivudine—Vomiting—Methotrexate—esophageal cancer	6.05e-05	0.000941	CcSEcCtD
Lamivudine—Rash—Methotrexate—esophageal cancer	6e-05	0.000933	CcSEcCtD
Lamivudine—Dermatitis—Methotrexate—esophageal cancer	5.99e-05	0.000932	CcSEcCtD
Lamivudine—Headache—Methotrexate—esophageal cancer	5.96e-05	0.000927	CcSEcCtD
Lamivudine—Nausea—Methotrexate—esophageal cancer	5.65e-05	0.000879	CcSEcCtD
Lamivudine—ABCC1—Metabolism—CYP26A1—esophageal cancer	1.53e-05	0.000125	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ADH7—esophageal cancer	1.52e-05	0.000124	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—EP300—esophageal cancer	1.52e-05	0.000124	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PLCE1—esophageal cancer	1.52e-05	0.000124	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CYP2A6—esophageal cancer	1.51e-05	0.000123	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ALOX15—esophageal cancer	1.49e-05	0.000122	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—PIK3CA—esophageal cancer	1.49e-05	0.000121	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—PIK3CA—esophageal cancer	1.49e-05	0.000121	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—PIK3CA—esophageal cancer	1.49e-05	0.000121	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ALDH2—esophageal cancer	1.48e-05	0.000121	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ADH1B—esophageal cancer	1.45e-05	0.000118	CbGpPWpGaD
Lamivudine—PGK1—Disease—PIK3CA—esophageal cancer	1.45e-05	0.000118	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ENO1—esophageal cancer	1.43e-05	0.000117	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTGS1—esophageal cancer	1.43e-05	0.000117	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.43e-05	0.000117	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ADH1B—esophageal cancer	1.43e-05	0.000117	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—CREBBP—esophageal cancer	1.43e-05	0.000117	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTO1—esophageal cancer	1.42e-05	0.000116	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—TPI1—esophageal cancer	1.42e-05	0.000116	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.41e-05	0.000115	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PSME2—esophageal cancer	1.41e-05	0.000115	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PSME1—esophageal cancer	1.41e-05	0.000115	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GSTT1—esophageal cancer	1.41e-05	0.000115	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.4e-05	0.000114	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	1.4e-05	0.000114	CbGpPWpGaD
Lamivudine—NME2—Metabolism—EP300—esophageal cancer	1.39e-05	0.000114	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CYP2A6—esophageal cancer	1.39e-05	0.000113	CbGpPWpGaD
Lamivudine—NME1—Metabolism—NOS3—esophageal cancer	1.39e-05	0.000113	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.38e-05	0.000113	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	1.38e-05	0.000113	CbGpPWpGaD
Lamivudine—ABCC1—Disease—XIAP—esophageal cancer	1.38e-05	0.000113	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—TYMP—esophageal cancer	1.38e-05	0.000113	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—TYMP—esophageal cancer	1.37e-05	0.000112	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ALDOB—esophageal cancer	1.36e-05	0.000111	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	1.36e-05	0.000111	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP26A1—esophageal cancer	1.34e-05	0.00011	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	1.34e-05	0.00011	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ADH1B—esophageal cancer	1.33e-05	0.000109	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP26A1—esophageal cancer	1.33e-05	0.000109	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ENO1—esophageal cancer	1.32e-05	0.000108	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTGS1—esophageal cancer	1.32e-05	0.000108	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.32e-05	0.000107	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GAPDH—esophageal cancer	1.31e-05	0.000107	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ALOX15—esophageal cancer	1.31e-05	0.000107	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.31e-05	0.000107	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CRABP1—esophageal cancer	1.3e-05	0.000106	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PSME2—esophageal cancer	1.3e-05	0.000106	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PSME1—esophageal cancer	1.3e-05	0.000106	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ALOX15—esophageal cancer	1.3e-05	0.000106	CbGpPWpGaD
Lamivudine—ABCC1—Disease—B2M—esophageal cancer	1.29e-05	0.000105	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—NOS3—esophageal cancer	1.28e-05	0.000104	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—TYMP—esophageal cancer	1.28e-05	0.000104	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PTGS2—esophageal cancer	1.27e-05	0.000104	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	1.26e-05	0.000102	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	1.25e-05	0.000102	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTO1—esophageal cancer	1.25e-05	0.000102	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—TPI1—esophageal cancer	1.25e-05	0.000102	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	1.24e-05	0.000101	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP26A1—esophageal cancer	1.24e-05	0.000101	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.24e-05	0.000101	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—TPI1—esophageal cancer	1.24e-05	0.000101	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTO1—esophageal cancer	1.24e-05	0.000101	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GNG7—esophageal cancer	1.24e-05	0.000101	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	1.24e-05	0.000101	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—BLVRB—esophageal cancer	1.23e-05	0.000101	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC52A3—esophageal cancer	1.23e-05	0.000101	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ENO1—esophageal cancer	1.23e-05	0.000101	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CYP1B1—esophageal cancer	1.22e-05	9.95e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PSME1—esophageal cancer	1.21e-05	9.91e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PSME2—esophageal cancer	1.21e-05	9.91e-05	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—PIK3CA—esophageal cancer	1.21e-05	9.88e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALOX15—esophageal cancer	1.21e-05	9.87e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ALDOB—esophageal cancer	1.2e-05	9.78e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ALDOB—esophageal cancer	1.19e-05	9.68e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CALR—esophageal cancer	1.17e-05	9.51e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ALDH2—esophageal cancer	1.16e-05	9.45e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GAPDH—esophageal cancer	1.15e-05	9.42e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTO1—esophageal cancer	1.15e-05	9.41e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—TPI1—esophageal cancer	1.15e-05	9.41e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CYP19A1—esophageal cancer	1.15e-05	9.35e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CRABP1—esophageal cancer	1.14e-05	9.33e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GAPDH—esophageal cancer	1.14e-05	9.32e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.13e-05	9.25e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CRABP1—esophageal cancer	1.13e-05	9.24e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FBXW7—esophageal cancer	1.13e-05	9.2e-05	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PIK3CA—esophageal cancer	1.13e-05	9.19e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CYP1B1—esophageal cancer	1.12e-05	9.14e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALDOB—esophageal cancer	1.11e-05	9.02e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTT1—esophageal cancer	1.1e-05	8.99e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP2A6—esophageal cancer	1.09e-05	8.89e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GNG7—esophageal cancer	1.09e-05	8.88e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.08e-05	8.85e-05	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.08e-05	8.79e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GNG7—esophageal cancer	1.08e-05	8.79e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	1.07e-05	8.7e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GAPDH—esophageal cancer	1.06e-05	8.69e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—CREBBP—esophageal cancer	1.06e-05	8.67e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CRABP1—esophageal cancer	1.05e-05	8.61e-05	CbGpPWpGaD
Lamivudine—NME1—Metabolism—EP300—esophageal cancer	1.05e-05	8.61e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CYP19A1—esophageal cancer	1.05e-05	8.6e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CA1—esophageal cancer	1.05e-05	8.56e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC10A2—esophageal cancer	1.05e-05	8.56e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—HMOX1—esophageal cancer	1.05e-05	8.53e-05	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.04e-05	8.52e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	1.03e-05	8.45e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ENO1—esophageal cancer	1.03e-05	8.43e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTGS1—esophageal cancer	1.03e-05	8.43e-05	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.03e-05	8.42e-05	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PIK3CA—esophageal cancer	1.03e-05	8.4e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ALDH2—esophageal cancer	1.02e-05	8.32e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PSME2—esophageal cancer	1.02e-05	8.3e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PSME1—esophageal cancer	1.02e-05	8.3e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	1.01e-05	8.26e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ALDH2—esophageal cancer	1.01e-05	8.23e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ABCB1—esophageal cancer	1e-05	8.19e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GNG7—esophageal cancer	1e-05	8.19e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—EP300—esophageal cancer	9.74e-06	7.95e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTT1—esophageal cancer	9.69e-06	7.91e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—HMOX1—esophageal cancer	9.61e-06	7.84e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CA2—esophageal cancer	9.59e-06	7.83e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTT1—esophageal cancer	9.59e-06	7.83e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP2A6—esophageal cancer	9.58e-06	7.82e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—NOS3—esophageal cancer	9.51e-06	7.76e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP2A6—esophageal cancer	9.48e-06	7.74e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.43e-06	7.7e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALDH2—esophageal cancer	9.4e-06	7.67e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ABCB1—esophageal cancer	9.22e-06	7.53e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	9.14e-06	7.46e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TGFBR2—esophageal cancer	9.12e-06	7.44e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ENO1—esophageal cancer	9.08e-06	7.41e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTGS1—esophageal cancer	9.08e-06	7.41e-05	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	9.08e-06	7.41e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTGS1—esophageal cancer	8.99e-06	7.34e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ENO1—esophageal cancer	8.99e-06	7.34e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	8.98e-06	7.33e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PSME2—esophageal cancer	8.95e-06	7.31e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PSME1—esophageal cancer	8.95e-06	7.31e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTT1—esophageal cancer	8.94e-06	7.3e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PLCE1—esophageal cancer	8.92e-06	7.28e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ADH7—esophageal cancer	8.92e-06	7.28e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	8.88e-06	7.25e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PSME2—esophageal cancer	8.86e-06	7.23e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PSME1—esophageal cancer	8.86e-06	7.23e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	8.85e-06	7.22e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP2A6—esophageal cancer	8.84e-06	7.21e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP1B1—esophageal cancer	8.78e-06	7.16e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTGS2—esophageal cancer	8.7e-06	7.1e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SMAD4—esophageal cancer	8.63e-06	7.04e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	8.42e-06	6.87e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ENO1—esophageal cancer	8.38e-06	6.84e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTGS1—esophageal cancer	8.38e-06	6.84e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	8.37e-06	6.83e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PSME2—esophageal cancer	8.26e-06	6.74e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PSME1—esophageal cancer	8.26e-06	6.74e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP19A1—esophageal cancer	8.25e-06	6.74e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ADH1B—esophageal cancer	7.82e-06	6.38e-05	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PIK3CA—esophageal cancer	7.8e-06	6.37e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP1B1—esophageal cancer	7.72e-06	6.3e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	7.65e-06	6.24e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP1B1—esophageal cancer	7.64e-06	6.24e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—HMOX1—esophageal cancer	7.53e-06	6.15e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TYMP—esophageal cancer	7.47e-06	6.1e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.39e-06	6.03e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	7.33e-06	5.99e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP26A1—esophageal cancer	7.27e-06	5.93e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP19A1—esophageal cancer	7.26e-06	5.93e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—EP300—esophageal cancer	7.23e-06	5.9e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ABCB1—esophageal cancer	7.23e-06	5.9e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PIK3CA—esophageal cancer	7.2e-06	5.88e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP19A1—esophageal cancer	7.19e-06	5.87e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	7.17e-06	5.86e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP1B1—esophageal cancer	7.12e-06	5.82e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALOX15—esophageal cancer	7.09e-06	5.78e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HIF1A—esophageal cancer	7.06e-06	5.76e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.97e-06	5.69e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TP53—esophageal cancer	6.97e-06	5.69e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTO1—esophageal cancer	6.76e-06	5.52e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TPI1—esophageal cancer	6.76e-06	5.52e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CREBBP—esophageal cancer	6.71e-06	5.47e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP19A1—esophageal cancer	6.7e-06	5.47e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—HMOX1—esophageal cancer	6.63e-06	5.41e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—HMOX1—esophageal cancer	6.56e-06	5.35e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALDOB—esophageal cancer	6.48e-06	5.29e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOS2—esophageal cancer	6.42e-06	5.24e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOTCH1—esophageal cancer	6.36e-06	5.19e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ABCB1—esophageal cancer	6.36e-06	5.19e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ABCB1—esophageal cancer	6.29e-06	5.14e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GAPDH—esophageal cancer	6.24e-06	5.09e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	6.23e-06	5.08e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CRABP1—esophageal cancer	6.18e-06	5.05e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CREBBP—esophageal cancer	6.17e-06	5.03e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—HMOX1—esophageal cancer	6.11e-06	4.99e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	6.02e-06	4.92e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—NOS3—esophageal cancer	6.01e-06	4.9e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GNG7—esophageal cancer	5.88e-06	4.8e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ABCB1—esophageal cancer	5.87e-06	4.79e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CREBBP—esophageal cancer	5.77e-06	4.71e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—NOS3—esophageal cancer	5.52e-06	4.51e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALDH2—esophageal cancer	5.51e-06	4.5e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTGS2—esophageal cancer	5.49e-06	4.48e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.47e-06	4.46e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CA—esophageal cancer	5.35e-06	4.37e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTT1—esophageal cancer	5.24e-06	4.28e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP2A6—esophageal cancer	5.18e-06	4.23e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOS3—esophageal cancer	5.16e-06	4.22e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTGS2—esophageal cancer	5.05e-06	4.12e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ENO1—esophageal cancer	4.91e-06	4.01e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTGS1—esophageal cancer	4.91e-06	4.01e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.91e-06	4.01e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PSME2—esophageal cancer	4.84e-06	3.95e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PSME1—esophageal cancer	4.84e-06	3.95e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CREBBP—esophageal cancer	4.83e-06	3.94e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ERBB2—esophageal cancer	4.83e-06	3.94e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTGS2—esophageal cancer	4.72e-06	3.86e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—EP300—esophageal cancer	4.57e-06	3.73e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—NOS3—esophageal cancer	4.33e-06	3.53e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CREBBP—esophageal cancer	4.25e-06	3.47e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CREBBP—esophageal cancer	4.21e-06	3.43e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—EP300—esophageal cancer	4.2e-06	3.43e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP1B1—esophageal cancer	4.18e-06	3.41e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN1A—esophageal cancer	4.13e-06	3.37e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTGS2—esophageal cancer	3.96e-06	3.23e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EP300—esophageal cancer	3.93e-06	3.21e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP19A1—esophageal cancer	3.93e-06	3.2e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CREBBP—esophageal cancer	3.92e-06	3.2e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—NOS3—esophageal cancer	3.81e-06	3.11e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—NOS3—esophageal cancer	3.77e-06	3.07e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HMOX1—esophageal cancer	3.58e-06	2.92e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NOS3—esophageal cancer	3.51e-06	2.87e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTGS2—esophageal cancer	3.48e-06	2.84e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTGS2—esophageal cancer	3.45e-06	2.81e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MYC—esophageal cancer	3.42e-06	2.79e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CA—esophageal cancer	3.38e-06	2.76e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EGFR—esophageal cancer	3.35e-06	2.73e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—EP300—esophageal cancer	3.29e-06	2.69e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTGS2—esophageal cancer	3.21e-06	2.62e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CA—esophageal cancer	3.11e-06	2.54e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CA—esophageal cancer	2.91e-06	2.37e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—EP300—esophageal cancer	2.9e-06	2.36e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—EP300—esophageal cancer	2.87e-06	2.34e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—EP300—esophageal cancer	2.67e-06	2.18e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CA—esophageal cancer	2.43e-06	1.99e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CREBBP—esophageal cancer	2.3e-06	1.88e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CA—esophageal cancer	2.14e-06	1.75e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CA—esophageal cancer	2.12e-06	1.73e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NOS3—esophageal cancer	2.06e-06	1.68e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CA—esophageal cancer	1.98e-06	1.61e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTGS2—esophageal cancer	1.88e-06	1.54e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—EP300—esophageal cancer	1.57e-06	1.28e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CA—esophageal cancer	1.16e-06	9.45e-06	CbGpPWpGaD
